ESMO26: Novel combo successes signal shift from frontline chemo in cold cancers
ESMO26: Novel combo successes signal shift from frontline chemo in cold cancers Clinical Trials Arena
ESMO26: Novel combo successes signal shift from frontline chemo in cold cancers Clinical Trials Arena
Персональная мРНК-вакцина почти вдвое снизила риски рецидива меланомы Хайтек+
Свыше 175 тысяч жителей Подмосковья прошли скрининг на рак кишечника Вести Подмосковья
В Чечне благодаря новой программе онкоскрининга выявили шесть случаев рака на ранней стадии ГТРК "Вайнах"
A powerful new AI system could help doctors detect pancreatic cancer years before it becomes visible on conventional scans. The technology, called REDMOD, identified hidden warning signs an average of 475 days before diagnosis and was nearly twice as sensitive as experienced radiologists. By spotting cancer-related…
Опухоль толстой кишки обнаружена после появления симптомов в виде кровавого стула. Vietnam.vn
Скрининг на рак кишечника прошли более 175 тысяч жителей Подмосковья radio1.ru
VHIO Presents New Precision Oncology Options for Patients with Thyroid Cancer at ESMO VHIO
Genmab shares jump 13% on colorectal cancer drug trial results Yahoo Finance
Biontech And Dualitybio Announce Topline Results Of Global Phase 3 Clinical Trial for Breast Cancer TradingView
Antengene presents clinical trial results for oncology pipeline at ESMO Vietnam Investment Review - VIR
Most advanced breast cancer patients treated in community settings, Phesi study finds Pharmafile
BioNTech and DualityBio Announce Topline Results of the DYNASTY-Breast02 Global Phase 3 Clinical Trial Evaluating Trastuzumab Pamirtecan in HR+/HER2-low Metastatic Breast Cancer WBOC TV
BioNTech and DualityBio Announce Topline Results of the DYNASTY-Breast02 Global Phase 3 Clinical Trial Evaluating Trastuzumab Pamirtecan in HR+/HER2-low Metastatic Breast Cancer Carroll County Mirror-Democrat
Maria Maddalena Laterza: The Challenges in Biomarker Testing in Gastroesophageal Cancer Oncodaily